• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过细胞系研究评估树枝状聚合物的安全性和功效。

Evaluation of dendrimer safety and efficacy through cell line studies.

机构信息

Pharmaceutics Research Laboratory, Department of Pharmaceutical Sciences, Dr. Hari Singh Gour University, Sagar (MP) 470 003, India.

出版信息

Curr Drug Targets. 2011 Sep;12(10):1478-97. doi: 10.2174/138945011796818135.

DOI:10.2174/138945011796818135
PMID:21443471
Abstract

Dendrimers, by virtue of their therapeutic value, have recently generated enormous interest among biomedical scientists. Advancement of dendrimeric nano-architecture with well defined size, shape and controlled exterior functionality embraces promise in biomedical and pharmaceutical applications such as drug delivery, solubilization, DNA transfection and diagnosis. Highly branched, monodisperse, stable molecular level and low polydispersity with micelle-like behavior possessing nano-scale container property distinguish these structures as inimitable and optimum carrier for those applications. Dendrimers has been evaluated for delivery of different types of bioactives inside the cells. Different types of techniques are being used for exploring dendrimer safety and efficacy via cell cytotoxicity assays, cell uptake studies by fluorescent microscopy, cell line studies, flow cytometry, gamma scintigraphy and confocal microscopy; are being used over a decade. Among these, cell line studies are widely used for ex vivo characterization of dendrimers and other nanocarriers. Cell lines are homogeneous population of cells, stable after mitosis, and have an unlimited capacity for division. This review focuses on the use of different cell line studies including anticancer drugs, anti-HIV drugs, anti-inflammatory drugs, anti-tubercular-drugs, photodynamic therapy, hormonal therapy employing dendritic nanocarrier.

摘要

树状聚合物由于其治疗价值,最近在生物医学科学家中引起了极大的兴趣。具有明确尺寸、形状和受控外部功能的树状纳米结构的进步在生物医药和制药应用中具有广阔的前景,如药物输送、增溶、DNA 转染和诊断。高度支化、单分散、稳定的分子水平和低多分散性,具有胶束样行为,具有纳米级容器特性,这些结构作为这些应用的独特和最佳载体。树状聚合物已被评估用于将不同类型的生物活性物质递送到细胞内。为了通过细胞毒性测定、荧光显微镜下的细胞摄取研究、细胞系研究、流式细胞术、γ闪烁和共聚焦显微镜研究来探索树状聚合物的安全性和功效,已经使用了不同类型的技术超过十年。其中,细胞系研究广泛用于树状聚合物和其他纳米载体的体外特性研究。细胞系是细胞的同质群体,有丝分裂后稳定,并且具有无限的分裂能力。这篇综述重点介绍了使用不同的细胞系研究,包括抗癌药物、抗 HIV 药物、抗炎药物、抗结核药物、光动力疗法和激素疗法,使用树状纳米载体。

相似文献

1
Evaluation of dendrimer safety and efficacy through cell line studies.通过细胞系研究评估树枝状聚合物的安全性和功效。
Curr Drug Targets. 2011 Sep;12(10):1478-97. doi: 10.2174/138945011796818135.
2
Pharmaceutical and biomedical potential of surface engineered dendrimers.表面工程树枝状大分子的药学与生物医学潜力
Crit Rev Ther Drug Carrier Syst. 2007;24(3):257-306. doi: 10.1615/critrevtherdrugcarriersyst.v24.i3.20.
3
Recent progress in dendrimer-based nanocarriers.基于树枝状大分子的纳米载体的最新进展。
Crit Rev Ther Drug Carrier Syst. 2006;23(6):437-95. doi: 10.1615/critrevtherdrugcarriersyst.v23.i6.10.
4
Dendrimers for pharmaceutical and biomedical applications.用于制药和生物医学应用的树枝状大分子。
J Biomater Sci Polym Ed. 2006;17(1-2):3-19. doi: 10.1163/156856206774879171.
5
Dendrimers as therapeutic agents: a systematic review.作为治疗剂的树枝状大分子:一项系统综述。
J Pharm Pharmacol. 2009 Aug;61(8):989-1003. doi: 10.1211/jpp/61.08.0002.
6
Understanding the Pharmaceutical Aspects of Dendrimers for the Delivery of Anticancer Drugs.了解用于递送达卡巴他赛药物的树枝状大分子的药物方面。
Curr Drug Targets. 2020;21(6):528-540. doi: 10.2174/1389450120666191031092259.
7
Dendrimers - from organic synthesis to pharmaceutical applications: an update.树枝状大分子——从有机合成到药物应用:最新进展
Pharm Dev Technol. 2015 Jan;20(1):22-40. doi: 10.3109/10837450.2013.862264. Epub 2013 Dec 4.
8
Recent progress in dendrimer-based nanomedicine development.基于树状高分子的纳米医学发展的最新进展。
Arch Pharm Res. 2018 Jun;41(6):571-582. doi: 10.1007/s12272-018-1008-4. Epub 2018 Feb 15.
9
Dendrimers: General Aspects, Applications and Structural Exploitations as Prodrug/Drug-delivery Vehicles in Current Medicine.树枝状聚合物:当前医学中作为前药/药物递送载体的一般方面、应用及结构利用
Mini Rev Med Chem. 2018 Feb 14;18(5):439-457. doi: 10.2174/1389557517666170512095151.
10
Dendrimers as versatile platform in drug delivery applications.树枝状大分子作为药物递送应用中的多功能平台。
Eur J Pharm Biopharm. 2009 Mar;71(3):445-62. doi: 10.1016/j.ejpb.2008.09.023. Epub 2008 Oct 17.

引用本文的文献

1
PEGylated PLGA nanoparticles: unlocking advanced strategies for cancer therapy.聚乙二醇化聚乳酸-羟基乙酸共聚物纳米颗粒:开启癌症治疗的先进策略
Mol Cancer. 2025 Jul 24;24(1):205. doi: 10.1186/s12943-025-02410-x.
2
Triphenylphosphine-Based Mitochondrial Targeting Nanocarriers: Advancing Cancer Therapy.基于三苯基膦的线粒体靶向纳米载体:推进癌症治疗
Clin Pharmacol. 2025 Jun 10;17:119-141. doi: 10.2147/CPAA.S526895. eCollection 2025.
3
Folate-engineered chitosan nanoparticles: next-generation anticancer nanocarriers.叶酸修饰壳聚糖纳米粒:新一代抗癌纳米载体。
Mol Cancer. 2024 Oct 31;23(1):244. doi: 10.1186/s12943-024-02163-z.
4
Transforming Healthcare with Nanomedicine: A SWOT Analysis of Drug Delivery Innovation.纳米医学引领医疗变革:药物输送创新的 SWOT 分析。
Drug Des Devel Ther. 2024 Aug 5;18:3499-3521. doi: 10.2147/DDDT.S470210. eCollection 2024.
5
Dendrimers as Non-Viral Vectors in Gene-Directed Enzyme Prodrug Therapy.树状高分子作为基因定向酶前药治疗中的非病毒载体。
Molecules. 2021 Oct 1;26(19):5976. doi: 10.3390/molecules26195976.
6
QbD Enabled Azacitidine Loaded Liposomal Nanoformulation and Its In Vitro Evaluation.基于质量源于设计的阿扎胞苷脂质体纳米制剂及其体外评价
Polymers (Basel). 2021 Jan 13;13(2):250. doi: 10.3390/polym13020250.
7
Applications and Limitations of Dendrimers in Biomedicine.树状高分子在生物医学中的应用及局限性。
Molecules. 2020 Sep 1;25(17):3982. doi: 10.3390/molecules25173982.
8
Transferrin/α-tocopherol modified poly(amidoamine) dendrimers for improved tumor targeting and anticancer activity of paclitaxel.转铁蛋白/α-生育酚修饰的聚酰胺-胺树枝状大分子用于提高紫杉醇的肿瘤靶向性和抗癌活性。
Nanomedicine (Lond). 2019 Dec;14(24):3159-3176. doi: 10.2217/nnm-2019-0128.
9
Targeting Groups Employed in Selective Dendrons and Dendrimers.用于选择性树枝状分子和树枝状聚合物的靶向基团
Pharmaceutics. 2018 Nov 8;10(4):219. doi: 10.3390/pharmaceutics10040219.
10
Generation dependent safety and efficacy of folic acid conjugated dendrimer based anticancer drug formulations.基于叶酸共轭树枝状大分子的抗癌药物制剂的代际依赖性安全性和有效性。
Pharm Res. 2015 Apr;32(4):1438-50. doi: 10.1007/s11095-014-1549-2. Epub 2014 Oct 18.